Sweden's Investor cuts losses
AFP/The Local · 15 Apr 2009, 15:28
Published: 15 Apr 2009 15:28 GMT+02:00
In the corresponding period of 2008 the group, which is controlled by the influential Wallenberg family, reported a loss of 8.93 billion kronor amid heavy market turbulence.
For the January to March period, Investor saw its net asset value drop by 24.7 percent to 109.7 billion kronor from 146 billion a year earlier.
"The general economy will be in disarray for most of 2009," Investor's chief executive Boerje Ekholm said in a statement.
Investor holds stakes in more than 130 companies worldwide.
Among its main holdings are Swiss-Swedish engineering group ABB, Anglo-Swedish pharmaceutical group Astra Zeneca, Swedish bank SEB, white goods maker Electrolux, industrial equipment manufacturer Atlas Copco, and the world leader in telecoms networks, Ericsson.
Investor, which is among the first of a slew of Swedish companies to present their first quarter earnings reports in the coming weeks, is considered a good indication of the Swedish business climate.
Ekholm said some economic indicators, such as unemployment, were expected to worsen.
"But in several areas it feels like the pace of economic contraction is slowing," he said.
"This could be a first step towards stabilisation," he added.
Investor said it saw the current economic crisis as an opportunity to make long-term investments.
"We see the current environment as providing unusually attractive opportunities and we are convinced that 2009 and 2010 will be great vintages for investments when measured over a 10-year horizon," it said.
The first quarter was marked by "successful" new share issues in bank SEB and outdoor power product maker Husqvarna.
"We believe SEB has a capital base that can sustain the bank through a difficult economic environment in its core markets including the Baltics," it said.
Credit ratings agency Moody's last week downgraded SEB's ratings due to its heavy exposure to the economic crisis in the Baltics, where the bank has invested heavily.
Investor also noted that it had acquired a 23-percent stake in Swedish pharmaceuticals group Biovitrum for 595 million kronor.